Barclays Upgrade Sends Humana Shares Surging 7% to $406.42

Humana's shares surged 7% to $406.42 after Barclays upgraded the company to Overweight from Neutral and raised its price target to $515, significantly higher than the previous target of $407.

The upgrade has propelled Humana's stock to a 60% year-to-date gain, outperforming its peers in the managed care sector. UnitedHealth Group's shares, on the other hand, rose by only 0.7% to $377.77.

The Barclays upgrade is driving the rally, and without any new information from Humana itself, the market's reaction is solely based on analyst sentiment. Momentum like this can attract more buyers, but it can also reverse quickly when the news flow goes quiet.